Phase 3CompletedAge-related condition

Women's Health Initiative (WHI)

Sponsor
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
Conditions
Bone Diseases; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Coronary Disease; Heart Diseases; Myocardial Ischemia; Osteoporosis; Postmenopause
Interventions
hormone replacement therapy; estrogens; progestins; estrogen replacement therapy; diet, fat-restricted; calcium; vitamin D; dietary supplements
Ages
adults, older adults
Registry
NCT00000611

Full record on ClinicalTrials.gov

From the registry

To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women. The three major components of the WHI are: a randomized controlled clinical trial of hormone replacement therapy (HRT), dietary modification (DM), and calcium/vitamin D supplementation (CaD); an observational study (OS); and a community prevention study (CPS). On October 1, 1997, administration of the WHI was transferred to the NHLBI where it is conducted as a consortium effort led by the NHLBI in cooperation with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Cancer Institute (NCI), and the National Institute on Aging (NIA).

History

  1. Last registry update

  2. Primary completion

  3. Registered

Papers citing this trial

In the news